Coverage / COR / Trade Card

COR

Cencora Inc

BUY 2026-08-11 Data 32 days old USD 330.21 Healthcare - Medical - DistributionAWAIT ENTRY
ACTIONABLEMethodology gates passed
69

Position levels

Currenttoday
USD 330.21
Buy <=wait / entry
USD 289.33
Trim >=take some off
USD 348.00
Thesis breakA material SEC enforcement action or binding legislation that materially raises ...
-

Scenario-weighted conviction

ProbabilityScoreContribution
Bull case37%100 / 10037.0
Base case50%62 / 10031.0
Bear case13%10 / 1001.3
Weighted conviction69 / 100 - BUY

Top risks

  • Quarterly earnings beat with $4.48 EPS vs $4.35 consensus and revenue of $84.75B vs $84.31B expected
  • Raised fiscal 2026 adjusted EPS guidance to $17.75 - $17.95 from prior $17.70 - $17.90 range
  • Third-quarter adjusted operating income growth of 17% and adjusted EPS growth of 12% driven by U.S. Healthcare Solutions specialty utilization
Read full report →

Research is for informational purposes only. Not financial advice. All analysis reflects the date of publication.